Clearline Capital’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-18,843
Closed -$875K 75
2018
Q3
$875K Buy
+18,843
New +$912K 0.52% 42
2018
Q1
Sell
-28,223
Closed -$1.12M 66
2017
Q4
$1.12M Sell
28,223
-5,858
-17% -$244K 0.58% 31
2017
Q3
$1.48M Buy
+34,081
New +$1.56M 1.08% 23
2017
Q1
Sell
-381,412
Closed -$14.6M 73
2016
Q4
$14.6M Buy
381,412
+256,779
+206% +$10.4M 6.65% 2
2016
Q3
$6.69M Buy
+124,633
New +$5.78M 2.09% 18

Other funds holding IMPV

Clearline Capital's IMPV Position: Q4 2018 in Review

Clearline Capital sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 18,843 shares — an estimated $875K sold.

Clearline Capital first reported a position in IMPV in Q3 2016 and held it in 5 quarters. The position peaked at $14.6M in Q4 2016. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Clearline Capital reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Clearline Capital sold 18,843 Imperva, Inc. shares in Q4 2018, an estimated $875K.
  • Clearline Capital first reported a position in Imperva, Inc. in Q3 2016 and held it in 5 quarters.
  • Clearline Capital's Imperva, Inc. position peaked at $14.6M in Q4 2016.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Clearline Capital's 13F filing for Q4 2018, filed 14 Feb 2019.